Prostate Biopsy: Possible follow-up by an urologist at 1 year and 2 years after recruitment. After 2 years, proposal for a 2-year end-of-study prostate biopsy to assess the presence or absence of prostate cancer.
The risk of prostate cancer is associated with lifestyle habits, such as diet and physical activity. Indeed, results of numerous studies suggest links between obesity, diabetes, inflammation and androgen and estrogen metabolism in the pathogenesis of prostate cancer.
The goal of BIOCaPPE study (Biomarkers and Prostate Cancer/ Prevention and Environment) is to identify biomarkers of prostate cancer risk that are potentially modifiable by environmental exposures (e.g. diet and physical activity).
A selection of few of the most promising biological markers will be evaluated in a cohort of more than 2000 men at high-risk of prostate cancer.
Such biomarkers would provide a practical approach to identify men at high risk of prostate cancer who could benefit from interventions aiming at reducing their risk. The biomarkers would also be useful to monitor the efficacy of the interventions on patient's lifestyle.
| Facility | City | Region | Status |
|---|---|---|---|
| Centre de Recherche du Centre Hospitalier de l'Université de Montréal | Montreal | Quebec | |
| McGill University Health Center | Montreal | Quebec | |
| CHU de Quebec- Université Laval | Québec | Quebec | |
| Centre de recherche du Centre hospitalier universitaire de Sherbrooke | Sherbrooke | Quebec |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT03383016 on ClinicalTrials.gov ↗ ← All trials in Canada